Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 24(5)2023 Mar 06.
Article in English | MEDLINE | ID: mdl-36902462

ABSTRACT

Currently, computed tomography and conventional X-ray radiography usually generate a micro-artifact around metal implants. This metal artifact frequently causes false positive or negative diagnoses of bone maturation or pathological peri-implantitis around implants. In an attempt to repair the artifacts, a highly specific nanoprobe, an osteogenic biomarker, and nano-Au-Pamidronate were designed to monitor the osteogenesis. In total, 12 Sprague Dawley rats were included in the study and could be chategorized in 3 groups: 4 rats in the X-ray and CT group, 4 rats in the NIRF group, and 4 rats in the sham group. A titanium alloy screw was implanted in the anterior hard palate. The X-ray, CT, and NIRF images were taken 28 days after implantation. The X-ray showed that the tissue surrounded the implant tightly; however, a gap of metal artifacts was noted around the interface between dental implants and palatal bone. Compared to the CT image, a fluorescence image was noted around the implant site in the NIRF group. Furthermore, the histological implant-bone tissue also exhibited a significant NIRF signal. In conclusion, this novel NIRF molecular imaging system precisely identifies the image loss caused by metal artifacts and can be applied to monitoring bone maturation around orthopedic implants. In addition, by observing the new bone formation, a new principle and timetable for an implant osseointegrated with bone can be established and a new type of implant fixture or surface treatment can be evaluated using this system.


Subject(s)
Dental Implants , Osseointegration , Rats , Animals , Osteogenesis , Rats, Sprague-Dawley , Maxilla , Prostheses and Implants , Titanium
2.
Blood ; 105(9): 3686-90, 2005 May 01.
Article in English | MEDLINE | ID: mdl-15626733

ABSTRACT

The promyelocytic leukemia (PML) gene, a tumor suppressor inactivated in acute promyelocytic leukemia (APL), regulates apoptosis induced by DNA damage. However, the molecular mechanisms by which PML modulates apoptosis following genotoxic stress are only partially elucidated. PML is essential for p53-dependent induction of programmed cell death upon gamma-irradiation through PML-nuclear body (NB)-mediated control of p53 acetylation. Here, we show that PML selectively regulates proapoptotic transcription factors upon different types of DNA damage. We find that Pml inactivation protects fibroblasts from UV-induced apoptosis in a p53-independent manner. We demonstrate that c-Jun is required for UV-induced apoptosis and that PML is essential for both c-Jun transcriptional activation and DNA binding upon UV radiation. We find that PML physically interacts with c-Jun and that upon UV radiation the PML-NBs reorganize into novel nuclear microspeckled structures (UV-NBs), where PML and c-Jun dynamically accumulate. These data identify a novel PML-dependent pathway for c-Jun transcriptional activation and induction of apoptosis in response to DNA damage and shed new light on the role of PML in tumor suppression.


Subject(s)
DNA Damage , Neoplasm Proteins/physiology , Nuclear Proteins/physiology , Proto-Oncogene Proteins c-jun/physiology , Transcription Factors/physiology , Animals , Apoptosis , Cells, Cultured , DNA Damage/radiation effects , Embryo, Mammalian/cytology , Mice , Mice, Knockout , Neoplasm Proteins/metabolism , Nuclear Proteins/metabolism , Promyelocytic Leukemia Protein , Protein Binding , Proto-Oncogene Proteins c-jun/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , Transcriptional Activation/radiation effects , Transfection , Tumor Suppressor Protein p53 , Tumor Suppressor Proteins , Ultraviolet Rays
3.
Mol Cell ; 10(4): 843-55, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12419228

ABSTRACT

During a screen to identify c-Jun activators, we isolated a cysteine protease, SuPr-1, that induced c-Jun-dependent transcription independently of c-Jun phosphorylation. SuPr-1 is a member of a new family of proteases that hydrolyze the ubiquitin-like modifier, SUMO-1. SuPr-1 hydrolyzed SUMO-1-modified forms of the promyelocytic leukemia gene product, PML, and altered the subcellular distribution of PML in nuclear PODs (PML oncogenic domains). SuPr-1 also altered the distribution of other nuclear POD-associated proteins, such as CBP and Daxx, that act as transcriptional regulators. SuPr-1 action on transcription was enhanced by PML, and SuPr-1 failed to activate transcription in PML-deficient fibroblasts. Our studies establish an important role for SUMO proteases in transcription.


Subject(s)
Cysteine Endopeptidases/metabolism , Neoplasm Proteins/metabolism , Nuclear Proteins , Transcription Factors/metabolism , Transcriptional Activation , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Cell Nucleus Structures/metabolism , Cysteine Endopeptidases/genetics , HeLa Cells , Humans , Mice , Molecular Sequence Data , Mutation , Neoplasm Proteins/genetics , Phosphorylation , Promoter Regions, Genetic , Promyelocytic Leukemia Protein , Protein Binding , Proto-Oncogene Proteins c-jun/metabolism , Sequence Homology, Nucleic Acid , Substrate Specificity , Transcription Factors/genetics , Tumor Suppressor Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...